Published in Drug Week, August 17th, 2007
"The promotions of Anne-Marie and Christine are a reflection of the significant contributions and leadership each has brought to the advancement and development of our product pipeline, specifically to our lead product, Hematide(TM)," said Robert Naso, Ph.D., executive vice president, Research and Development at Affymax. "We are fortunate to have access to their depth of knowledge and years of experience in their respective fields and look forward to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.